Jonathan T Ma1, Christina Tang2, Le Kang3, Judith A Voynow1, Bruce K Rubin4. 1. Department of Pediatrics, Children's Hospital of Richmond at VCU, Richmond, VA. 2. Department of Chemical and Life Science Engineering, Virginia Commonwealth University, Richmond, VA. 3. Department of Biostatistics, Virginia Commonwealth University, Richmond, VA. 4. Department of Pediatrics, Children's Hospital of Richmond at VCU, Richmond, VA. Electronic address: bruce.rubin@vcuhealth.org.
Abstract
BACKGROUND: Cystic fibrosis (CF) airway secretions are abnormal, contributing to decreased clearance and a cycle of infection and inflammation. CF sputum properties may predict disease progression. We hypothesized that sputum viscoelasticity and clearance abnormalities would inversely correlate with pulmonary function during exacerbation and that sputum properties would return to baseline after therapy. METHODS: We collected sputa longitudinally from 13 subjects with CF with moderate to severe lung disease during both clinical stability and exacerbation. Dynamic rheology was analyzed, using a cone-and-plate rheometer. Mucociliary clearability was measured on mucus-depleted frog palate, cough clearability in a simulated cough machine, and sputum hydration as percent solids was measured following lyophilization. RESULTS: Elastic modulus G' and viscous modulus G'' increased during exacerbation and returned to baseline levels with recovery (P < .05 for both). Solid content did not change. Sputum mucociliary clearability decreased during exacerbations (P < .01) but not cough clearance. FEV1 % predicted was inversely correlated with G' and G'' (P < .01 for both). The regression slope of the natural log-transformed G' and G'' vs FEV1 % predicted was statistically homogeneous among subjects (estimated common slope m = -3.84, P < .001 and m = -8.53, P < .0001, respectively). CONCLUSIONS: Among these subjects with CF, there is a striking identity of the slope defining the relationship between ln G' or ln G'' and FEV1. There are dramatic increases in dynamic viscosity and elasticity during a pulmonary exacerbation with return to baseline at recovery. This suggests that sputum viscoelastic properties are tightly associated with lung function and disease status.
BACKGROUND:Cystic fibrosis (CF) airway secretions are abnormal, contributing to decreased clearance and a cycle of infection and inflammation. CF sputum properties may predict disease progression. We hypothesized that sputum viscoelasticity and clearance abnormalities would inversely correlate with pulmonary function during exacerbation and that sputum properties would return to baseline after therapy. METHODS: We collected sputa longitudinally from 13 subjects with CF with moderate to severe lung disease during both clinical stability and exacerbation. Dynamic rheology was analyzed, using a cone-and-plate rheometer. Mucociliary clearability was measured on mucus-depleted frog palate, cough clearability in a simulated cough machine, and sputum hydration as percent solids was measured following lyophilization. RESULTS: Elastic modulus G' and viscous modulus G'' increased during exacerbation and returned to baseline levels with recovery (P < .05 for both). Solid content did not change. Sputum mucociliary clearability decreased during exacerbations (P < .01) but not cough clearance. FEV1 % predicted was inversely correlated with G' and G'' (P < .01 for both). The regression slope of the natural log-transformed G' and G'' vs FEV1 % predicted was statistically homogeneous among subjects (estimated common slope m = -3.84, P < .001 and m = -8.53, P < .0001, respectively). CONCLUSIONS: Among these subjects with CF, there is a striking identity of the slope defining the relationship between ln G' or ln G'' and FEV1. There are dramatic increases in dynamic viscosity and elasticity during a pulmonary exacerbation with return to baseline at recovery. This suggests that sputum viscoelastic properties are tightly associated with lung function and disease status.
Authors: Carla Cristina Souza Gomez; Paloma Lopes Francisco Parazzi; Karl Jan Clinckspoor; Renan Marrichi Mauch; Francisco Benedito Teixeira Pessine; Carlos Emilio Levy; Andressa Oliveira Peixoto; Maria Ângela Gonçalves Oliveira Ribeiro; Antônio Fernando Ribeiro; Douglas Conrad; Paul Marquis Quinton; Fernando Augusto Lima Marson; José Dirceu Ribeiro Journal: Clin Drug Investig Date: 2020-02 Impact factor: 2.859
Authors: Michael J Kratochvil; Gernot Kaber; Sally Demirdjian; Pamela C Cai; Elizabeth B Burgener; Nadine Nagy; Graham L Barlow; Medeea Popescu; Mark R Nicolls; Michael G Ozawa; Donald P Regula; Ana E Pacheco-Navarro; Samuel Yang; Vinicio A de Jesus Perez; Harry Karmouty-Quintana; Andrew M Peters; Bihong Zhao; Maximilian L Buja; Pamela Y Johnson; Robert B Vernon; Thomas N Wight; Carlos E Milla; Angela J Rogers; Andrew J Spakowitz; Sarah C Heilshorn; Paul L Bollyky Journal: JCI Insight Date: 2022-06-22
Authors: Bethany D Batson; Bryan T Zorn; Giorgia Radicioni; Stephanie S Livengood; Tadahiro Kumagai; Hong Dang; Agathe Ceppe; Phillip W Clapp; Michael Tunney; J Stuart Elborn; Noel G McElvaney; Marianne S Muhlebach; Richard C Boucher; Michael Tiemeyer; Matthew C Wolfgang; Mehmet Kesimer Journal: Am J Respir Cell Mol Biol Date: 2022-08 Impact factor: 7.748
Authors: Vivian Y Lin; Niroop Kaza; Susan E Birket; Harrison Kim; Lloyd J Edwards; Jennifer LaFontaine; Linbo Liu; Marina Mazur; Stephen A Byzek; Justin Hanes; Guillermo J Tearney; S Vamsee Raju; Steven M Rowe Journal: Eur Respir J Date: 2020-01-30 Impact factor: 16.671
Authors: David B Hill; Robert F Long; William J Kissner; Eyad Atieh; Ian C Garbarine; Matthew R Markovetz; Nicholas C Fontana; Matthew Christy; Mehdi Habibpour; Robert Tarran; M Gregory Forest; Richard C Boucher; Brian Button Journal: Eur Respir J Date: 2018-12-06 Impact factor: 16.671
Authors: Apparao B Kummarapurugu; Shuo Zheng; Abigail Pulsipher; Justin R Savage; Jonathan Ma; Bruce K Rubin; Thomas P Kennedy; Judith A Voynow Journal: Am J Respir Cell Mol Biol Date: 2021-02 Impact factor: 6.914
Authors: Anna M van Heeckeren; Morgan T Sutton; David R Fletcher; Craig A Hodges; Arnold I Caplan; Tracey L Bonfield Journal: Front Pharmacol Date: 2021-05-13 Impact factor: 5.810
Authors: Rosalie S Linssen; Guihong Chai; Jonathan Ma; Apparao B Kummarapurugu; Job B M van Woensel; Reinout A Bem; Logan Kaler; Gregg A Duncan; Lei Zhou; Bruce K Rubin; Qingguo Xu Journal: Am J Respir Cell Mol Biol Date: 2021-01 Impact factor: 6.914